Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries

Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries
ShareXFacebook

(MedPage Today) -- CHICAGO -- Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients in low-resource countries with recurrent or metastatic head and neck squamous...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Protein Won't Solve Our Nutrition Problem
MedPage Today

Protein Won't Solve Our Nutrition Problem

(MedPage Today) -- Buffalo Wild Wings now offers an unusual new drink: "Espresso Proteini." Marketed for National Espresso Martini Day, the $12 drink includes 10 grams of Muscle Milk protein powder with a signature Buffalo dry rub rim. While the...

Read more →
Advertisement